21 results
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
29 Jun 21
Current report (foreign)
7:38am
to Planet Financial Performance Values-Based Governance Global Corporate Social Responsibility Legal Disclaimers Appendix Reconciliations 03 06 08 09 … , more than 60% of our research and development (R&D) pipeline is being developed with partners around the world. We have 16 Global Corporate Social Responsibility Program
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
28 May 21
Current report (foreign)
6:01am
workplaces. Takeda’s ESG commitment – including its Access to Medicines strategy and Global Corporate Social Responsibility Program – is evident through
6-K
b9pk tpov
11 May 21
Current report (foreign)
6:08am
6-K
EX-99.1
by2xyhnn4ryoalz8sjh
17 Dec 20
Current report (foreign)
6:01am
6-K
9w4jq9lnbhchyhid
29 Jul 20
Current report (foreign)
6:07am
6-K
EX-1
drd4h4 oo3m
27 May 20
Current report (foreign)
6:03am
6-K
clwdbsbs0 kkbb27rdeb
13 May 20
Current report (foreign)
6:03am
6-K
1ts0idxsnd19h 569
14 Jan 20
Current report (foreign)
6:56am
6-K
EX-99.1
34q6q045x9n19
10 Jan 20
Better Health, Brighter Future 2019 SUSTAINABLE VALUE REPORT Takeda Pharmaceutical Company Limited
6:36am
6-K
EX-99.1
1rn9x cadp2
14 Nov 19
Current report (foreign)
6:26am
424B3
guzoicbm
14 Nov 19
Prospectus supplement
6:10am
F-4/A
qhkmwpj
12 Nov 19
Registration of securities (foreign) (amended)
9:50am
F-4
i20a j8vlc4
9 Aug 19
Registration of securities (foreign)
6:27am
20-F
0yuk mp09
27 Jun 19
Annual report (foreign)
6:41am
20FR12B/A
yqef65bqtw4xewbas8q7
17 Dec 18
Initial registration of securities (foreign private issuers) (amended)
6:14am
20FR12B
dkbtr fh2irhdxm2
6 Dec 18
Initial registration of securities (foreign private issuers)
10:39am